<code id='F569218E43'></code><style id='F569218E43'></style>
    • <acronym id='F569218E43'></acronym>
      <center id='F569218E43'><center id='F569218E43'><tfoot id='F569218E43'></tfoot></center><abbr id='F569218E43'><dir id='F569218E43'><tfoot id='F569218E43'></tfoot><noframes id='F569218E43'>

    • <optgroup id='F569218E43'><strike id='F569218E43'><sup id='F569218E43'></sup></strike><code id='F569218E43'></code></optgroup>
        1. <b id='F569218E43'><label id='F569218E43'><select id='F569218E43'><dt id='F569218E43'><span id='F569218E43'></span></dt></select></label></b><u id='F569218E43'></u>
          <i id='F569218E43'><strike id='F569218E43'><tt id='F569218E43'><pre id='F569218E43'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:2695
          George Yancopoulos on the 2024 Breakthrough Summit East stage.
          George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

          George Yancopoulos is in touch with his teenage self.

          After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

          advertisement

          “My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          With Wegovy coverage, Medicare patients may face high costs
          With Wegovy coverage, Medicare patients may face high costs

          ApersonholdsaWegovyinjectionpen.KayanaSzymczakforSTATMedicareconfirmedthisweekthatitwillcoverNovoNor

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          With Wegovy coverage, Medicare patients may face high costs

          ApersonholdsaWegovyinjectionpen.KayanaSzymczakforSTATMedicareconfirmedthisweekthatitwillcoverNovoNor